Inventor
CARDOZO MARIO
US13 patents
⚠️ This page may combine multiple inventors who share the name “CARDOZO MARIO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
NURIX THERAPEUTICS INC
7 patentsUS11530229B2Dec 20, 2022
Cyano cyclobutyl compounds for CBL-B inhibition and uses thereof
NURIX THERAPEUTICS INC12 citations84
US11464802B2Oct 11, 2022
3-substituted piperidine compounds for Cbl-b inhibition, and use thereof
NURIX THERAPEUTICS INC14 citations84
US11401267B2Aug 2, 2022
Substituted benzyl-triazole compounds for Cbl-b inhibition, and further uses thereof
NURIX THERAPEUTICS INC11 citations84
US11951133B2Apr 9, 2024
3-substituted piperidine compounds for Cbl-b inhibition, and use thereof
NURIX THERAPEUTICS INC2 citations71
US12485144B2Dec 2, 2025
3-substituted piperidine compounds for Cbl-b inhibition, and use thereof
NURIX THERAPEUTICS INC1 citations62
US12234230B2Feb 25, 2025
Substituted benzyl-triazole compounds for Cbl-b inhibition, and further uses thereof
NURIX THERAPEUTICS INC1 citations62
US12049471B2Jul 30, 2024
Cyano cyclobutyl compounds for Cbl-b inhibition and uses thereof
NURIX THERAPEUTICS INC1 citations61
BOEHRINGER INGELHEIM PHARMA
6 patentsUS6770639B2Aug 3, 2004
Heterocyclic compounds useful as inhibitors of tyrosine kinases
BOEHRINGER INGELHEIM PHARMA205 citations98
US6506769B2Jan 14, 2003
Heterocyclic compounds useful as inhibitors of tyrosine kinases
BOEHRINGER INGELHEIM PHARMA240 citations98
US6268365B1Jul 31, 2001
Src family SH2 domain inhibitors
BOEHRINGER INGELHEIM PHARMA31 citations92
US6054470AApr 25, 2000
Src family SH2 domain inhibitors
BOEHRINGER INGELHEIM PHARMA7 citations73
US6284768B1Sep 4, 2001
Src family SH2 domain inhibitors
BOEHRINGER INGELHEIM PHARMA4 citations62
US5837704ANov 17, 1998
2-heteroaryl-5,11-dihydro-6H-dipyrido 3,2-B:2',3'-E! 1,4!diazepines and their use in the prevention or treatment of HIV infection
BOEHRINGER INGELHEIM PHARMA3 citations56